190 related articles for article (PubMed ID: 38059189)
1. Analysis of clinicopathological features and prognostic factors of breast cancer brain metastasis.
Chen YR; Xu ZX; Jiang LX; Dong ZW; Yu PF; Zhang Z; Gu GL
World J Clin Oncol; 2023 Nov; 14(11):445-458. PubMed ID: 38059189
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors of Brain Metastasis and Prognosis in HER2-Positive Breast Cancer: A Single-Institution Retrospective Analysis from China.
Cai SL; Wang ZH; Chen XG; Han L; Gong GX; Chen YP; Lin XQ; Ma T; Chen HD
Front Oncol; 2022; 12():905065. PubMed ID: 35832552
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.
Saraf A; Grubb CS; Hwang ME; Tai CH; Wu CC; Jani A; Lapa ME; Andrews JIS; Vanderkelen S; Isaacson SR; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Cheng SK; Connolly EP; Wang TJC
J Neurooncol; 2017 Sep; 134(2):453-463. PubMed ID: 28674973
[TBL] [Abstract][Full Text] [Related]
4. CILP, a Putative Gene Associated With Immune Infiltration in Breast Cancer Brain Metastases.
Sun X; Yang N; Zhou X; Dai H; Li Q; Feng A; Xu G; Liu Y; Xu L; Zhang Z; Yang Z; Li X
Front Genet; 2022; 13():862264. PubMed ID: 35711946
[TBL] [Abstract][Full Text] [Related]
5. Interactive effects of molecular subtypes with tumor size and extracranial metastatic pattern on risk of brain metastasis in breast cancer patients: A population-based study.
Shen B; Li J; Yang M; Liu K; Zhang J; Li W; Zhang Y; Wang K
Cancer Med; 2023 Mar; 12(6):6547-6557. PubMed ID: 36353772
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
[TBL] [Abstract][Full Text] [Related]
7. The clinical, molecular, and therapeutic implications of time from primary diagnosis to brain metastasis in lung and breast cancer patients.
Ge H; Zhu K; Sun Q; Wang H; Liu H; Ge J; Liu C; Liang P; Lv Z; Bao H
Cancer Med; 2024 Jun; 13(11):e7364. PubMed ID: 38847084
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer.
Xiao W; Li X; Yang A; Chen B; Zheng S; Zhang G; Deng W; Liao N
Front Oncol; 2020; 10():431. PubMed ID: 32309214
[TBL] [Abstract][Full Text] [Related]
9. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
[TBL] [Abstract][Full Text] [Related]
10. Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.
Sambade MJ; Prince G; Deal AM; Trembath D; McKee M; Garrett A; Keith K; Ramirez J; Midkiff B; Blackwell K; Sammons S; Leone JP; Brufsky A; Morikawa A; Brogi E; Seidman A; Ewend M; Carey LA; Moschos SJ; Hamilton RL; Vincent B; Anders C
Breast Cancer Res Treat; 2019 Jul; 176(2):321-328. PubMed ID: 31016641
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
Morikawa A; Wang R; Patil S; Diab A; Yang J; Hudis CA; McArthur HL; Beal K; Seidman AD
Clin Breast Cancer; 2018 Oct; 18(5):353-361. PubMed ID: 29337140
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
13. Construction and Validation of New Nomograms to Predict Risk and Prognostic Factors of Breast Cancer Bone Metastasis in Asian Females: A Population-Based Retrospective Study.
Deng J; Zhang D; Zhang W; Li J
Int J Gen Med; 2021; 14():8881-8902. PubMed ID: 34866932
[TBL] [Abstract][Full Text] [Related]
14. New insights into HER2-low breast cancer brain metastasis: A retrospective analysis.
Xu H; Wang Y; Li L; Han Y; Wu Y; Sa Q; Xu B; Wang J
Breast; 2024 Feb; 73():103669. PubMed ID: 38176304
[TBL] [Abstract][Full Text] [Related]
15. Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies.
Mounsey LA; Deal AM; Keith KC; Benbow JM; Shachar SS; Zagar T; Dees EC; Carey LA; Ewend MG; Anders CK
Clin Breast Cancer; 2018 Feb; 18(1):29-37. PubMed ID: 28867445
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy.
Leone JP; Lee AV; Brufsky AM
Cancer Med; 2015 Jul; 4(7):989-94. PubMed ID: 25756607
[TBL] [Abstract][Full Text] [Related]
17. Clinico-pathologic factors and survival of patients with breast cancer diagnosed with de novo brain metastasis: a national cancer database analysis.
Hijazi A; Mohanna M; Sabbagh S; HerrĂ¡n M; Dominguez B; Sarna K; Nahleh Z
Breast Cancer Res Treat; 2024 Apr; ():. PubMed ID: 38683296
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases.
Hulsbergen AFC; Lamba N; Claes A; Kavouridis VK; Lin NU; Smith TR; Verhoeff JJC; Broekman MLD
World Neurosurg; 2019 Aug; 128():e157-e164. PubMed ID: 31035019
[TBL] [Abstract][Full Text] [Related]
19. A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer.
Wang Z; Wang H; Ding X; Chen X; Shen K
Ther Adv Med Oncol; 2020; 12():1758835920932674. PubMed ID: 32550867
[TBL] [Abstract][Full Text] [Related]
20. Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.
Darlix A; Griguolo G; Thezenas S; Kantelhardt E; Thomssen C; Dieci MV; Miglietta F; Conte P; Braccini AL; Ferrero JM; Bailleux C; Jacot W; Guarneri V
J Neurooncol; 2018 Jun; 138(2):369-382. PubMed ID: 29488184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]